Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Guardant Health, Inc. - Common Stock
(NQ:
GH
)
108.81
-2.44 (-2.19%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 25, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Guardant Health, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio?
↗
January 12, 2025
These mid-cap stocks had impressive gains last week, including Inari Medical, Unifirst Corporation, and Walgreens. Are they in your portfolio?
Via
Benzinga
Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection
January 07, 2025
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
January 02, 2025
From
Guardant Health, Inc.
Via
Business Wire
Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care
December 20, 2024
From
Guardant Health, Inc.
Via
Business Wire
COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics
December 19, 2024
From
COTA Inc.
Via
Business Wire
Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer
December 18, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Share New Research Demonstrating Value of Liquid Biopsy Tests, Real-world Data and AI Analytics in Tailoring Treatment Approaches for Breast Cancer at 2024 San Antonio Breast Cancer Symposium
December 09, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Stock Sees RS Rating Jump To 83
↗
November 20, 2024
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83.
Via
Investor's Business Daily
Deciphering Disruption: Inside Cathie Wood's Latest Plays
November 16, 2024
Cathie Wood's recent stock market activity offers a glimpse into her evolving investment strategy and the potential of disruptive technologies.
Via
MarketBeat
Topics
Artificial Intelligence
ETFs
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 13, 2024
From
Guardant Health, Inc.
Via
Business Wire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
↗
November 12, 2024
The rock star money manager is starting to roll with the rallying market.
Via
The Motley Fool
Smaller Cap Biotechs Are In Season: How Are We Doing?
↗
November 07, 2024
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range.
Via
Talk Markets
Why Guardant Health Stock Blasted 13% Higher on Thursday
↗
November 07, 2024
Via
The Motley Fool
HubSpot Posts Better-Than-Expected Results, Joins Under Armour, Lyft, Wolverine World Wide, Zillow And Other Big Stocks Moving Higher On Thursday
↗
November 07, 2024
Via
Benzinga
Guardant Health Rockets 25% On An 'Impressive' Beat Following Exact Sciences' Flop
↗
November 07, 2024
The company also hiked its outlook for the year and guided to 20% growth in clinical volumes next year.
Via
Investor's Business Daily
Guardant Health Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
November 06, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Participate in Upcoming Investor Conferences
November 01, 2024
From
Guardant Health, Inc.
Via
Business Wire
Why Guardant Health Stock Was the Picture of Health Today
↗
October 30, 2024
There's nothing like free publicity to help goose the sales of a relatively new product.
Via
The Motley Fool
Guardant Health Named to TIME’s List of the Best Inventions of 2024
October 30, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Colorectal Cancer Screening at ACG 2024
October 28, 2024
From
Guardant Health, Inc.
Via
Business Wire
Roberto A. Mignone Joins Guardant Health Board of Directors
October 24, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Report Third Quarter 2024 Financial Results on November 6, 2024
October 15, 2024
From
Guardant Health, Inc.
Via
Business Wire
FDA Clears Exact Sciences' Next-Generation Colorectal Cancer Diagnostic Test
↗
October 04, 2024
Exact Sciences' Cologuard Plus test, now FDA-approved, offers a non-invasive screening option for adults 45+ at average risk for colorectal cancer. The test outperformed fecal immunochemical tests in...
Via
Benzinga
GOZILA Study Published in Nature Medicine Shows Patients With Advanced Cancer Who Receive Liquid Biopsy-Guided Treatment Using Guardant360 CDx Survive Twice as Long
September 18, 2024
From
Guardant Health, Inc.
Via
Business Wire
Sky Harbour Group, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
September 17, 2024
Via
Benzinga
iTeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
September 16, 2024
Via
Benzinga
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
↗
September 16, 2024
Via
Benzinga
Guardant Health to Share Data at ESMO 2024 Further Demonstrating Strong Performance of Its Precision Oncology Technology in Multiple Advanced Tumor Types
September 13, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health and Policlinico Gemelli Announce Partnership to Establish A Dedicated In-House Liquid Biopsy Testing Service in Italy
September 10, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 27, 2024
From
Guardant Health, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today